However, last year, two patients died from liver failure after receiving Elevidys. This led to Sarepta Therapeutics having to ...

Through the first nine months of 2025, the company generated $422 million in revenue -- representing an increase of 39% year ...

Lastly, Johnson & Johnson is an exceptional income stock. The company is a Dividend King, or a corporation with at least 50 consecutive years of payout increases under its belt. For all those reasons, ...

Well, my prediction is Nvidia still has plenty of room to run, and it will do so in 2026 thanks to this one thing. First, ...

This aspect of its business provides visibility into future earnings over the next decade and beyond. Right now, GE Vernova ...

Last year, Nvidia ( NVDA +2.98%) chief Jensen Huang suggested it may take 20 years for that to happen, then a few months ...

Highlighting its momentum, the online brokerage company added over 1 million net new accounts in 2025. And, for the full year ...

Last year was not a good one for Dexcom ( DXCM +1.95%). The medical device specialist lagged the market, and even with a bit ...

There's no getting around the fact that oil and gas exploration and production companies' prospects are tied to oil prices.

Sandisk has been around for a little while, but it's completely understandable if you've overlooked it because for a while it ...

The No. 1 financial goal for most Americans is to stop working. Once they retire, their primary goal becomes not running out of money.

The Fidelity Wise Origin Bitcoin Fund tracks bitcoin directly, while the Bitwise Crypto Industry Innovators ETF invests in ...